Codes / ICD10CM / T36.1X5D

T36.1X5D Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter

Summary

This condition represents an adverse reaction to cephalosporins or other beta-lactam antibiotics during a subsequent encounter. It applies when a patient experiences harmful effects from these antibiotics after initial treatment, requiring clinical assessment and documentation of the event’s context. Documentation should specify the type of beta-lactam antibiotic, the nature of the adverse effect, and encounter details.

Causes

Adverse effects may result from allergic reactions, idiosyncratic responses, drug interactions, or cumulative toxicity related to cephalosporins or other beta-lactam antibiotics. Underlying factors such as prior exposure, immune sensitization, or metabolic changes can contribute to the reaction.

Risk Factors

  • Prior history of beta-lactam allergies or sensitivities.
  • Polypharmacy increasing interaction risks.
  • Renal or hepatic impairment affecting drug metabolism.
  • Repeated or prolonged antibiotic use.
  • Inadequate patient education on medication use.

Symptoms

  • Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
  • Allergic: Rash, urticaria, anaphylaxis.
  • Systemic: Fever, hypotension, organ dysfunction (e.g., nephrotoxicity).
  • Neurological: Dizziness, confusion, or seizures in severe cases.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, medication history, and exclusion of other causes. Laboratory tests (e.g., allergy testing, organ function studies) may support the assessment. Documentation should link the adverse effect to the specific beta-lactam antibiotic and encounter timing.

Treatment Options

Management focuses on discontinuing the offending antibiotic, providing supportive care (e.g., antihistamines, fluids), and addressing complications. Severe reactions (e.g., anaphylaxis) require immediate intervention (e.g., epinephrine). Alternative antibiotics may be selected based on allergy history.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most mild cases resolve with discontinuation and supportive care. Severe reactions may require extended monitoring. Follow-up ensures resolution and prevents recurrence, with documentation of any long-term effects.

Complications

  • Anaphylaxis or severe allergic reactions.
  • Organ damage (e.g., kidney or liver injury).
  • Persistent hypersensitivity to beta-lactam antibiotics.
  • Delayed treatment due to misdiagnosis.

Lifestyle & Prevention

  • Avoid known allergens or cross-reactive antibiotics.
  • Educate patients on medication use and allergy risks.
  • Use allergy testing or desensitization protocols when necessary.
  • Monitor for early signs of adverse effects during treatment.

When to Seek Professional Help

Seek care if symptoms worsen (e.g., difficulty breathing, swelling) or new symptoms develop. Immediate attention is needed for severe reactions (e.g., anaphylaxis). Follow up with a healthcare provider if symptoms persist or recur.

Tips for Medical Coders

Document the specific beta-lactam antibiotic, nature of the adverse effect, and encounter details (e.g., subsequent encounter). Ensure the code aligns with clinical findings and encounter timing. Verify that the adverse effect is directly linked to the antibiotic and not another cause.

Book a walkthrough

T36.1X5D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.